1-5 of 5
Yasuhiko Tsukushi, MD PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Relationship between Molecular Response of BCR-ABL1 Transcripts within 6 Months and Deep Molecular Response at 18 Months to Dasatinib Treatment for Newly Diagnosed Patients with CML-CP

Daigo Michimata, MD, Kazunori Murai, MD PhD, Yasuro Miyairi, MD, PhD, Yoshiaki Okano, MD, PhD, Yuuzou Suzuki, MD, PhD, Hiroyuki Hamada, MD, Akiyoshi Sato, MD, PhD, Tatsuo Oyake, Shugo Kowata, MD, PhD, Yasuhiko Tsukushi, MD, PhD, Norifumi Sugawara, MD, PhD, Akihiro Otsu, MD, PhD, Kenji Shimosegawa, MD, Shigeki Ito, MD, PhD, Yoji Ishida, MD, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2928.
https://doi.org/10.1182/blood-2019-125066
Published: 2019
Journal Articles

Doripenem Versus Meropenem As the First-Line Mono-Therapy in High-Risk Febrile Neutropenic Patients with Acute Leukemia: A Randomized, Controlled Trial

Tatsuo Oyake, Norifumi Sugawara, MD, PhD, Shinri Miyajima, MD, Kazuki Kiyohara, MD, Maki Nishiya, MD PhD, Tadashi Shimoyama, MD PhD, Yuka Takemasa-Fujisawa, MD PhD, Ryosei Sasaki, MD PhD, Wataru Izumita, MD, Yasuhiko Tsukushi, MD, PhD, Akihiro Otsu, MD, PhD, Takahiro Mine, MD, Takeshi Sugawara, MD, Yuzo Suzuki, MD PhD, Yoshiaki Okano, MD, PhD, Ichiro Hanamura, MD PhD, Shugo Kowata, MD, PhD, Shigeki Ito, MD, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4865.
https://doi.org/10.1182/blood-2019-131305
Published: 2019
Journal Articles

Comparison of Micafungin and Liposomal Amphotericin B for Empirical Antifungal Therapy in Febrile Neutropenic Patients with Acute Myeloid Leukemia: A Randomized Controlled Trial

Tatsuo Oyake, MD, PhD, Yuka Fujisawa, MD, PhD, Norifumi Sugawara, MD, PhD, Ryousei Sasaki, MD, PhD, Wataru Izumita, MD, Takahiro Mine, MD, Maki Asahi, MD, PhD, Yuzo Suzuki, MD, PhD, Yoshiaki Okano, MD, Yukiteru Fujishima, MD, Yasuhiko Tsukushi, MD, PhD, Yusei Aoki, MD, Shugo Kowata, MD, PhD, Ichiro Hanamura, MD, PhD, Kazunori Murai, MD, PhD, Shigeki Ito, MD, PhD, Yoji Ishida, MD, PhD
Journal: Blood
Blood (2016) 128 (22): 1607.
https://doi.org/10.1182/blood.V128.22.1607.1607
Published: 2016
Journal Articles

First-Line Dasatinib Treatment of CML-CP Leads to Earlier Achievement of MMR and MR4.5 with High Safety

Kazunori Murai, MD, PhD, Kohei Yamaguchi, MD, Shigeki Ito, MD, PhD, Takuto Miyagishima, MD, PhD, Motohiro Shindo, MD PhD, Kentaro Wakasa, MD, PhD, Mitsue Inomata, MD, PhD, Takahiro Nagashima, MD, PhD, Takeshi Kondo, MD PhD, Nozomu Fujimoto, MD, PhD, Satoshi Yamamoto, PhD MD, Masakatsu Yonezumi, MD, PhD, Tatsuo Oyake, MD, PhD, Shugo Kowata, MD PhD, Yasuhiko Tsukushi, MD PhD, Takahiro Mine, MD, Kuniaki Meguro, MD PhD, Kazuhiko Ikeda, MD PhD, Reiko Watanabe, MD PhD, Souichi Saito, MD, PhD, Shinji Sato, MD, PhD, Takaaki Chou, MD, PhD, Kohmei Kubo, MD, PhD, Koji Oba, PhD, Junichi Sakamoto, MDPhD, Yoji Ishida, MD, PhD
Journal: Blood
Blood (2016) 128 (22): 3102.
https://doi.org/10.1182/blood.V128.22.3102.3102
Published: 2016
Journal Articles

Velocity of Early BCR-ABL Transcript Elimination As an Optimized Predictor of Deep Molecular Response in Chronic Myeloid Leukemia Patients in Chronic Phase on Treatment with Dasatinib

Kazunori Murai, MD PhD, Kohei Yamaguchi, MD, Shigeki Ito, MD PhD, Tomoaki Akagi, Kazuei Ogawa, MD PhD, Inomata Mitsue, Kuniaki Meguro, Reiko Watanabe, MD PhD, Takuto Miyagishima, MD, PhD, Kentaro Wakasa, Motohiro Shindo, MD PhD, Yasuhiko Tsukushi, MD PhD, Kohmei Kubo, MD, PhD, Koji Oba, PhD, Junichi Sakamoto, MDPhD, Yoji Ishida, MD, PhD
Journal: Blood
Blood (2015) 126 (23): 4052.
https://doi.org/10.1182/blood.V126.23.4052.4052
Published: 2015